Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2005.059014v1, 2006; 10.1373/clinchem.2005.059014
This Article
Right arrow Full Text (PDF)
Right arrow 059014.Supplemental Data
Right arrow All Versions of this Article:
clinchem.2005.059014v1
52/6/1080    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fitzpatrick, E.
Right arrow Articles by Wieder, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fitzpatrick, E.
Right arrow Articles by Wieder, R.

Received on August 9, 2005
Accepted on March 8, 2006

Cancer Diagnostics

Microfluidic Techniques for Single-Cell Protein Expression Analysis

Ethan Fitzpatrick 1, Sterling McBride 2, Jonathan Yavelow 1, Saltanat Najmi 3, Peter Zanzucchi 2, Robert Wieder 3*

1 Department of Biology, Rider University, Lawrenceville, NJ
2 Sarnoff Corporation, Princeton, NJ
3 Division of Medical Oncology/Hematology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, NJ

* To whom correspondence should be addressed. E-mail: wiederro{at}umdnj.edu.

Background: The analysis of single cells obtained from needle aspirates of tumors is constrained by the need for processing. To this end, we investigated two microfluidic approaches to measure the expression of surface proteins in single cancer cells or in small populations (<50 cells).

Methods: One approach involved indirect fluorescence labeling of cell-surface proteins and channeling of cells in a microfluidic device past a fluorescence detector for signal quantification and analysis. A second approach channeled cells in a microfluidic device over detection zones coated with ligands to surface proteins and measured rates of passage and of retardation based on transient interactions between surface proteins and ligands.

Results: The fluorescence device detected integrin {alpha}5 expression induced by fibroblast growth factor-2 (FGF-2) treatment in MCF-7 cells and that of Her-2/neu in SK-BR-3 cells compared with controls. Experiments measuring passage retardation showed significant differences in passage rates between FGF-2-treated and untreated MCF-7 cells over reaction regions coated with fibronectin and antibody to integrin {alpha}5{beta}1 compared with control regions. Blocking peptides reversed the retardation, indicating specificity.

Conclusions: Immunofluorescence detection in a microfluidic channel has the potential for assaying surface protein expression in a few individual cells and could permit the development of future iterations not requiring cell handling. The flow retardation device represents the first application of this technology for assessing cell-surface protein expression in cancer cells and may provide a way for analyzing expression profiles of single cells without preanalytical manipulation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Association for Clinical Chemistry.